Alnylam Pharmaceuticals
ALNY
#505
Rank
โ‚ฌ41.47 B
Marketcap
313,91ย โ‚ฌ
Share price
-0.70%
Change (1 day)
34.52%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: 423,28ย โ‚ฌ Euro on 2025-10-20

Lowest end of day price: 3,40ย โ‚ฌ Euro on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2026

Annual Stock Price Performance

Year Performance
2026-7.74%
2025 70.21%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
57,56ย โ‚ฌ 1.35%๐Ÿ‡บ๐Ÿ‡ธ USA
641,83ย โ‚ฌ-1.23%๐Ÿ‡บ๐Ÿ‡ธ USA
18,95ย โ‚ฌ-3.55%๐Ÿ‡บ๐Ÿ‡ธ USA
1,10ย โ‚ฌ-1.53%๐Ÿ‡บ๐Ÿ‡ธ USA
7,03ย โ‚ฌ 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
123,16ย โ‚ฌ-2.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
40,73ย โ‚ฌ-1.31%๐Ÿ‡ซ๐Ÿ‡ท France
28,05ย โ‚ฌ-0.26%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel